Request Demo
Last update 08 May 2025
Beijing Aitaipu Biomedical Technology Co., Ltd
Private Company|2014|Beijing Shi, China
Private Company|2014|Beijing Shi, China
Last update 08 May 2025
Overview
Basic Info
Introduction Beijing aitaipu Biomedical Technology Co Ltd. is composed of Aitai Pu Biomedical Anticancer Drug Research Center and Tianjin Aitai Pu Pharmaceutical Co., Ltd. It is a high-tech enterprise jointly established by well-known medical experts and scholars at home and abroad. The company mainly engages in the research, development, production and sales of targeted biological polypeptide drugs, chemical drugs and traditional Chinese medicine. The company currently has proprietary intellectual property rights and has developed a new targeted biological polypeptide anticancer drug ATAP (national first-class new drug) in the United States. |
Tags
Neoplasms
Small molecule drug
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
No Data
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
CTR20231201
评价注射用ATAP-M8在晚期实体瘤患者中单次/多次给药的安全性、耐受性和药代动力学特征Ⅰ期临床研究
[Translation] Phase I clinical study to evaluate the safety, tolerability and pharmacokinetic characteristics of single/multiple administration of ATAP-M8 for injection in patients with advanced solid tumors
100 Clinical Results associated with Beijing Aitaipu Biomedical Technology Co., Ltd
Login to view more data
Login to view more data
100 Deals associated with Beijing Aitaipu Biomedical Technology Co., Ltd
Login to view more data
100 Translational Medicine associated with Beijing Aitaipu Biomedical Technology Co., Ltd
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 23 Sep 2025
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 1 Clinical
1
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free